Clemens Isert

Clemens Isert currently serves as an AI Scientist at VantAI since December 2023. Prior experience includes a PhD Student role at ETH Zürich from February 2020 to September 2023, focusing on computer-assisted drug design with an emphasis on artificial intelligence for molecular property prediction and drug interaction analysis. Clemens also held a position as a Visiting Scientist at Novartis Institutes for BioMedical Research in 2022, worked as a Fellow Intern at McKinsey & Company in late 2019, and possessed software development experience at DataHow AG in 2018. Additionally, a background in social media and public relations was gained while at Chemtogether in 2018, and earlier academic support was provided as a Student Teaching Assistant at ETH Zürich. Educational credentials include a Visiting Research Scientist status at the Massachusetts Institute of Technology, along with degrees from ETH Zürich and ongoing studies at The University of Texas at Austin.